Description
Synedica Retatrutide 40mg – Triple Agonist Metabolic Research System
Explore the next generation of metabolic science with Synedica Retatrutide 40mg, a highly advanced compound for incretin receptor research.
Unlike traditional single- or dual-targeting peptides, Retatrutide stands out as a powerful triple agonist, targeting GLP-1, GIP, and Glucagon receptors simultaneously. This multi-pathway approach allows investigators to study synergistic effects on metabolic function, lipid metabolism, and glucose homeostasis in comprehensive laboratory models.
Designed for experimental consistency and precision, each box is an all-in-one kit engineered for a seamless laboratory experience.
Key Features for Researchers
•Triple Receptor Agonist: Simultaneously activates GLP-1, GIP, and Glucagon receptors for maximum data yield in metabolic efficiency studies.
•Stable Research Protocols: Formulated to support extended observational cycles in controlled environments.
•Complete All-in-One Kit: No need to purchase extra laboratory supplies—everything required for your protocol is included right in the box.
•Precise Volumetric Delivery: Designed for smooth, targeted, and highly accurate dispensing.
What’s Included in the Box?
Each premium kit is fully equipped with:
•1 Pre-filled Dispensing Pen (delivering 4 x 10mg yields for a total of 40mg)
•12 Disposable Tips (ensuring fresh, sterile tips for every application)
•1 Detailed Technical Manual (comprehensive guidance for proper storage and laboratory usage)
Storage & Handling Instructions
•Temperature Control: Must be stored in a laboratory refrigerator between 2°C to 8°C to maintain structural stability. Do not freeze.
•Handling: For laboratory and in-vitro use only. Please consult the included instruction book for step-by-step guidance on how to safely set your volumetric dose and use the pen.
⚠️ Research Disclaimer: This product is strictly for research and laboratory purposes only. It is not intended for human consumption, animal use, or medical application. All researchers must handle this compound in accordance with institutional safety protocols.
